Authors: Crossingham I; Turner S; Ramakrishnan S; et al.
Source: BMJ evidence-based medicine [BMJ Evid Based Med] 2022 Jun; Vol. 27 (3), pp. 178-184. Date of Electronic Publication: 2021 Jul 19. Abstract: In people with mild asthma poor adherence to regular therapy is common and increases the risk of exacerbations, morbidity and mortality. The use of fixed dose combination inhalers containing an inhaled corticosteroid (ICS) and a fast-acting β 2 -agonist (FABA) is established in moderate asthma, but they may also have potential utility in mild asthma. Objectives: To evaluate the efficacy and safety of single combined FABA/ICS inhaler only used as needed in people with mild asthma. Full text available here
0 Comments
Leave a Reply. |
The following databases were searched:
EMBASE, MEDLINE, PsycINFO, BNI, CINAHL, to find ELHT staff publications Specialties
All
Archives
August 2022
|
Contact Us:
library@elht.nhs.uk Learning Centre Library Royal Blackburn Teaching Hospital 01254 734312 or Ext 84312 Find us |
Staffed Opening Hours
Mon 08:30-16:30 Tue 08:30-16:30 Wed 08:30-16:30 Thu 08:30-16:30 Fri 08:30-16:00 24/7 access to both libraries is available - please see library staff
|